1 |
Special Systematic Reviews 2009 Current status of Liver Diseases in Korea: Report from the Epidemiology Study Group of the KASL. Annual report of Korean central cancer registry program, Ministry of Health and Welfare, Republic of Korea 2002.
|
2 |
Kim JH, Choi MS, Lee H, et al. Clinical features and prognosis of Hepatocerullar carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006;21: 588-594.
DOI
ScienceOn
|
3 |
Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocerullar carcinoma. J Korean Med Sci 1998;13:306-310.
DOI
|
4 |
Ministry of Health and Welfare. Korea Central Cancer Registry. Cancer incidence in Korea, 2007.
|
5 |
Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocerullar carcinoma compared with hepatitis B virus in elderly patients in a hepatitis Bendemic area. Cancer 1993;72:2564-2567.
DOI
ScienceOn
|
6 |
Jung SH, Kim BH, Joung YH, et al. Clinical features of hepatocerullar carcinoma in the 1990s. Korean J Gastroenterol 2003;42:322-329.
|
7 |
Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocerullar carcinoma in a hepatitis B virus endemic area. J Gastroenterol Hepatol 2008;23:467-473.
DOI
ScienceOn
|
8 |
Lee HS, Ryu JK, Jung SH, Kim YC. A prospective study on the incidence and the risk factors ofThe development of hepatocerullar carcinoma in patients with the liver cirrhosis in Korea. Korean J Gastroenterol 1993;25:116-122.
|
9 |
Han BH, Lee SW, Koo JY, Park BC. Prevalence of hepatitis B and C viral markers in patients with hepatocerullar carcinoma in Korea. J Korean Cancer Assoc 1991;23:723-727.
|
10 |
Huh K, Lee JK, Choi SY, Hong SI, Lee DS. A study on the prevalence of HBsAg and anti-HCV in patients with hepatocerullar carcinoma: comparative study with healthy blood donors. Korean J Clin Pathol 1998;18:458-463.
|
11 |
Park JW. Practice guideline for diagnosis and treatment of hepatocerullar carcinoma. Korean J Hepatol 2004;10:88-98.
|
12 |
Lee JG, Kang CM, Park JS, et al. The actual five-year survival rate of hepatocerullar carcinoma patients after curative resection. Yonsei Med J 2006;47:105-112.
DOI
ScienceOn
|
13 |
Wang HJ, Lee H. Surgical treatment of hepatocerullar carcinoma. Korean J Gastroenterol 2005;45:247-257.
|
14 |
Kim HJ, Hwang YJ, Kim JY, et al. Comparision of surgical outcomes and long-term survival between limited and major hepatic resection for hepatocerullar carcinoma less than 5 cm. J Korean Surg Soc 2010;78:29-34.
DOI
ScienceOn
|
15 |
Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease- free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001;19: 3037-3044.
DOI
|
16 |
Choi SB, Kim KS, Park YN, et al. The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. J Korean Med Sci 2009;24:242-247.
DOI
ScienceOn
|
17 |
Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009;249:195-202.
DOI
ScienceOn
|